Prevention of Type 2 diabetes: fact or fiction?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.18, 2007-12, pp. : 3147-3158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes

By Ramsey Scott D. Clarke Lauren D.

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 329-339

Adis International

Access to resources Recommend Favorite

Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

By André J. Scheen

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2537-2565

Adis International

Access to resources Recommend Favorite

The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

By Grassi Guido

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2421-2424

Informa Healthcare

Access to resources Recommend Favorite